Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427
Children · 28.04.2026 · 13 (5) · 607
DOI: 10.3390/children13050607 ↗Kurz gefasst
Kommentar in der Zeitschrift Children, online erschienen am 28.04.2026. Verfasst von Nicola Improda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neuroendocrine Diseases and Obesity Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Via Egiziaca a Forcella 18, 80139 Na…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Dear Editor, [...]
Autor:innen und Institutionen
- Neuroendocrine Diseases and Obesity Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Via Egiziaca a Forcella 18, 80139 Naples, Italy.
ORCID-Profile: Nicola Improda, Giada Ballarin
Zitieren
APA
Improda, N., & Ballarin, G. (2026). Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427. Children, 13(5), 607. https://doi.org/10.3390/children13050607
Vancouver
Improda N, Ballarin G. Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427. Children. 2026;13(5):607. doi:10.3390/children13050607
BibTeX
@article{Improda2026,
author = {Improda, Nicola and Ballarin, Giada},
title = {Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427},
journal = {Children},
year = {2026},
volume = {13},
number = {5},
pages = {607},
doi = {10.3390/children13050607}
}
EUVIMED